Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
Guardant Health, Inc. filed this Current Report on Form 8-K on November 4, 2021, to announce financial results for the fiscal quarter ended September 30, 2021. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Select Market under the symbol "GH".
Key Financial Metrics
This filing serves as a notification of the release of financial results and incorporates the press release by reference. The text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release (Exhibit 99.1) for detailed financial data.
Material Changes
The filing does not contain specific comparative data or details regarding material changes versus the prior comparable period within the body of the report. Such information is contained in the referenced press release.
Guidance, Outlook, and Risks
The filing does not include specific guidance, outlook, management commentary, or risk factors in its text. The report explicitly states that the information furnished, including the press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that Section, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 4, 2021) for specific Q3 2021 revenue and net loss figures.
- Verify cash position and liquidity metrics in the full press release, as they are not listed in this 8-K summary.
- Confirm any updated full-year 2021 guidance provided in the referenced press release.
- Note that the information in this 8-K is not deemed "filed" under Section 18 of the Exchange Act.